Citation 49610

KUPCHAN,SM: AYNEHCHI,Y: CASSADY,JM: SCHNOES,HK: BURLINGAME,AL:. (1969). TUMOR INHIBITORS XL. THE ISOLATION AND STRUCTURAL ELUCIDATION OF ELEPHANTIN AND ELEPHANTOPIN, TWO NOVEL SESQUITERPENOID TUMOR INHIBITORS FROM ELEPHANTOPUS ELATUS.. 34()

Citation Details

Title	TUMOR INHIBITORS XL. THE ISOLATION AND STRUCTURAL ELUCIDATION OF ELEPHANTIN AND ELEPHANTOPIN, TWO NOVEL SESQUITERPENOID TUMOR INHIBITORS FROM ELEPHANTOPUS ELATUS.
Authors	KUPCHAN,SM: AYNEHCHI,Y: CASSADY,JM: SCHNOES,HK: BURLINGAME,AL:
Year	1969
Volume	34
Issue

Summary

Year: 1969

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTED	ELEPHANTOL ACETATEELEPHANTOPIN,TETRAHYDRO:ELEPHANTIN,TETRAHYDRO:ELEPHANTOL,DIHYDRO:	None

Elephantopus elatus (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELEPHANTIN	WEAK ACTIVITY
2	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELEPHANTIN	ACTIVE
3	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELEPHANTIN	ACTIVE
4	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATAYIELD IS MORE THAN 100 MGM	ELEPHANTIN	None
5	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELEPHANTOPIN	INACTIVE
6	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELEPHANTOPIN	ACTIVE
7	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELEPHANTOPIN	ACTIVE
8	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATAYIELD IS MORE THAN 100 MGM	ELEPHANTOPIN	None
9	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE
10	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
11	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE